Macrocytic anemia classification

Revision as of 14:17, 21 September 2012 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

Macrocytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Macrocytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Macrocytic anemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Macrocytic anemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Macrocytic anemia classification

CDC on Macrocytic anemia classification

Macrocytic anemia classification in the news

Blogs on Macrocytic anemia classification

Directions to Hospitals Treating Macrocytic anemia

Risk calculators and risk factors for Macrocytic anemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Macrocytosis is the enlargement of red blood cells with near-constant haemoglobin concentration, and is defined by a mean corpuscular volume (MCV) of greater than 100 femtolitres (the precise criterion varies between laboratories).

Classifcation

Megaloblastic anemia is an anemia (of macrocytic classification) which results from inhibition of DNA synthesis in red blood cell production. It is often due to deficiency of vitamin B12 and/or folic acid. It can be the result of a lack of intrinsic factor (which lack interferes with B12 absorption), causing pernicious anemia, or with other antimetabolites which poison DNA production, such as chemotherapeutic agents. It is characterized by many large immature and dysfunctional red blood cells (megaloblasts) in the bone marrow, and also by hypersegmented or multisegmented neutrophils. [1] [2]

References

  1. Babior BM, Bunn HF, Megaloblastic Anemias. Harrison’s Principles of Internal Medicine. 13th Ed. 1994: 1726-1732. ISBN 0070323704
  2. Toh BH, van Driel IR, Gleeson PA. Mechanisms of Disease: Pernicious Anemia. NEJM 1997;337:1441.

gl:Anemia megaloblástica he:אנמיה מגלובלסטית it:Anemia megaloblastica sl:Megaloblastna anemija sr:Мегалобластна анемија


Template:WikiDoc Sources